

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.71971957 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.71971957 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.49164457 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.49164457 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.22502926 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.89253822 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.85594214 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.85594214 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.85594214 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.71331019 |
| 11 | urea cycle (GO:0000050) | 5.61779552 |
| 12 | urea metabolic process (GO:0019627) | 5.61779552 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 5.59836530 |
| 14 | cysteine metabolic process (GO:0006534) | 5.46796503 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.42243637 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.32433996 |
| 17 | nitrogen cycle metabolic process (GO:0071941) | 5.20897419 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.18268437 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.02961314 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.02471807 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.00839541 |
| 22 | regulation of protein activation cascade (GO:2000257) | 4.99301152 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95023295 |
| 24 | protein carboxylation (GO:0018214) | 4.93678500 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.93678500 |
| 26 | bile acid metabolic process (GO:0008206) | 4.87952287 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 4.78358139 |
| 28 | tolerance induction (GO:0002507) | 4.76351069 |
| 29 | regulation of triglyceride catabolic process (GO:0010896) | 4.73435489 |
| 30 | regulation of fibrinolysis (GO:0051917) | 4.73317079 |
| 31 | regulation of complement activation (GO:0030449) | 4.69427936 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.61525326 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 4.60230477 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.60230477 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.60230477 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.55146219 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.53386114 |
| 38 | bile acid and bile salt transport (GO:0015721) | 4.50890157 |
| 39 | phospholipid efflux (GO:0033700) | 4.45298044 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.42444740 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.37403983 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.37403983 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.34531649 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.33097502 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.33097502 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.30226240 |
| 47 | coenzyme catabolic process (GO:0009109) | 4.25920969 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.22688936 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 4.19506796 |
| 50 | low-density lipoprotein particle remodeling (GO:0034374) | 4.19387897 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.12531176 |
| 52 | glycine metabolic process (GO:0006544) | 4.11884689 |
| 53 | plasma lipoprotein particle assembly (GO:0034377) | 4.06888577 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.05190531 |
| 55 | lysine metabolic process (GO:0006553) | 4.03033201 |
| 56 | lysine catabolic process (GO:0006554) | 4.03033201 |
| 57 | amine catabolic process (GO:0009310) | 3.96309032 |
| 58 | cellular biogenic amine catabolic process (GO:0042402) | 3.96309032 |
| 59 | cholesterol efflux (GO:0033344) | 3.96002988 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 3.92781842 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 3.92646316 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.91195438 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 3.90969775 |
| 64 | ethanol oxidation (GO:0006069) | 3.87262176 |
| 65 | glutamate metabolic process (GO:0006536) | 3.85986156 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 3.85913427 |
| 67 | cellular glucuronidation (GO:0052695) | 3.83037686 |
| 68 | arginine metabolic process (GO:0006525) | 3.81743135 |
| 69 | complement activation, classical pathway (GO:0006958) | 3.77694738 |
| 70 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76954536 |
| 71 | plasma lipoprotein particle organization (GO:0071827) | 3.74953538 |
| 72 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74163923 |
| 73 | protein K11-linked deubiquitination (GO:0035871) | 3.71270638 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 3.71158136 |
| 75 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70901527 |
| 76 | protein-lipid complex assembly (GO:0065005) | 3.68789626 |
| 77 | activated T cell proliferation (GO:0050798) | 3.68625966 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68281288 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67233950 |
| 80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67233950 |
| 81 | fucose catabolic process (GO:0019317) | 3.66781775 |
| 82 | L-fucose metabolic process (GO:0042354) | 3.66781775 |
| 83 | L-fucose catabolic process (GO:0042355) | 3.66781775 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 3.66644835 |
| 85 | NAD biosynthetic process (GO:0009435) | 3.66043950 |
| 86 | complement activation (GO:0006956) | 3.65734202 |
| 87 | cofactor catabolic process (GO:0051187) | 3.63979850 |
| 88 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.63979647 |
| 89 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.63979647 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.63755006 |
| 91 | phospholipid homeostasis (GO:0055091) | 3.62580938 |
| 92 | drug catabolic process (GO:0042737) | 3.60765777 |
| 93 | sterol homeostasis (GO:0055092) | 3.59027941 |
| 94 | protein activation cascade (GO:0072376) | 3.58691500 |
| 95 | cytolysis (GO:0019835) | 3.58027770 |
| 96 | cellular ketone body metabolic process (GO:0046950) | 3.57173311 |
| 97 | acute-phase response (GO:0006953) | 3.56035247 |
| 98 | protein-lipid complex subunit organization (GO:0071825) | 3.54891891 |
| 99 | fibrinolysis (GO:0042730) | 3.54104661 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.53765068 |
| 101 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.53066513 |
| 102 | serine family amino acid biosynthetic process (GO:0009070) | 3.50184601 |
| 103 | intestinal cholesterol absorption (GO:0030299) | 3.49961915 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 3.48345400 |
| 105 | regulation of memory T cell differentiation (GO:0043380) | 3.44947996 |
| 106 | organic acid catabolic process (GO:0016054) | 3.43125149 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.43125149 |
| 108 | interferon-gamma production (GO:0032609) | 3.40444844 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.39703673 |
| 110 | negative T cell selection (GO:0043383) | 3.37647887 |
| 111 | short-chain fatty acid metabolic process (GO:0046459) | 3.34195074 |
| 112 | behavioral response to nicotine (GO:0035095) | 3.24590165 |
| 113 | positive regulation of defense response to virus by host (GO:0002230) | 3.20999236 |
| 114 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19147700 |
| 115 | negative thymic T cell selection (GO:0045060) | 3.18950851 |
| 116 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16731154 |
| 117 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13801858 |
| 118 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.09107556 |
| 119 | regulation of germinal center formation (GO:0002634) | 3.05727561 |
| 120 | positive T cell selection (GO:0043368) | 3.04422011 |
| 121 | protein K63-linked deubiquitination (GO:0070536) | 3.02941542 |
| 122 | negative regulation of cell killing (GO:0031342) | 2.97892817 |
| 123 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97892817 |
| 124 | alpha-beta T cell differentiation (GO:0046632) | 2.95690853 |
| 125 | DNA deamination (GO:0045006) | 2.93201287 |
| 126 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.89921883 |
| 127 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.89402174 |
| 128 | positive regulation of mRNA catabolic process (GO:0061014) | 2.87666077 |
| 129 | alpha-beta T cell activation (GO:0046631) | 2.76225771 |
| 130 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.75620759 |
| 131 | T-helper cell differentiation (GO:0042093) | 2.75620759 |
| 132 | cellular response to exogenous dsRNA (GO:0071360) | 2.74761409 |
| 133 | histone H3-K4 trimethylation (GO:0080182) | 2.73168103 |
| 134 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.72154902 |
| 135 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.71454094 |
| 136 | negative regulation of bone resorption (GO:0045779) | 2.70495110 |
| 137 | negative regulation of interleukin-1 production (GO:0032692) | 2.68549088 |
| 138 | establishment of protein localization to Golgi (GO:0072600) | 2.66444096 |
| 139 | positive regulation of granulocyte differentiation (GO:0030854) | 2.64565282 |
| 140 | regulation of defense response to virus by host (GO:0050691) | 2.64290931 |
| 141 | RNA destabilization (GO:0050779) | 2.63154140 |
| 142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.60151606 |
| 143 | cellular response to interleukin-15 (GO:0071350) | 2.58420647 |
| 144 | T cell selection (GO:0045058) | 2.58327277 |
| 145 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56046962 |
| 146 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.55881451 |
| 147 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.54500556 |
| 148 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.54145987 |
| 149 | positive regulation of protein homooligomerization (GO:0032464) | 2.53278291 |
| 150 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.53028774 |
| 151 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.52382054 |
| 152 | cAMP catabolic process (GO:0006198) | 2.50375411 |
| 153 | negative regulation of mast cell activation (GO:0033004) | 2.50300004 |
| 154 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.49775404 |
| 155 | T cell differentiation involved in immune response (GO:0002292) | 2.48813233 |
| 156 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.48813233 |
| 157 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.48813233 |
| 158 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.48550688 |
| 159 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45152245 |
| 160 | cellular response to interferon-beta (GO:0035458) | 2.44802155 |
| 161 | positive thymic T cell selection (GO:0045059) | 2.44275052 |
| 162 | response to interleukin-15 (GO:0070672) | 2.43621731 |
| 163 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.43190019 |
| 164 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.43190019 |
| 165 | negative regulation of telomere maintenance (GO:0032205) | 2.41164435 |
| 166 | negative regulation of interleukin-6 production (GO:0032715) | 2.40640399 |
| 167 | defense response to protozoan (GO:0042832) | 2.39230088 |
| 168 | cytidine deamination (GO:0009972) | 2.39180360 |
| 169 | cytidine metabolic process (GO:0046087) | 2.39180360 |
| 170 | cytidine catabolic process (GO:0006216) | 2.39180360 |
| 171 | protein targeting to Golgi (GO:0000042) | 2.38875567 |
| 172 | regulation of T-helper 1 type immune response (GO:0002825) | 2.38763639 |
| 173 | regulation of regulatory T cell differentiation (GO:0045589) | 2.38605332 |
| 174 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.38260644 |
| 175 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.37106355 |
| 176 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.36831699 |
| 177 | organelle membrane fusion (GO:0090174) | 2.36552372 |
| 178 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.36381472 |
| 179 | platelet dense granule organization (GO:0060155) | 2.36319418 |
| 180 | response to muramyl dipeptide (GO:0032495) | 2.36263264 |
| 181 | T cell migration (GO:0072678) | 2.35888993 |
| 182 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.35172678 |
| 183 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.35138784 |
| 184 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.35054039 |
| 185 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.35054039 |
| 186 | protein K48-linked deubiquitination (GO:0071108) | 2.34880532 |
| 187 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.34203819 |
| 188 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.33708647 |
| 189 | detection of light stimulus involved in visual perception (GO:0050908) | 2.33708647 |
| 190 | regulation of chronic inflammatory response (GO:0002676) | 2.33262146 |
| 191 | mast cell activation (GO:0045576) | 2.33069623 |
| 192 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.32778446 |
| 193 | B cell homeostasis (GO:0001782) | 2.31441408 |
| 194 | regulation of mRNA catabolic process (GO:0061013) | 2.30793908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.27229833 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.41222561 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.79021438 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.60764707 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.63960850 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.45105816 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.22676131 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.06466141 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60175325 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.33562829 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.31830452 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.77780435 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.63518916 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55623379 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.47522286 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.44191796 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.37680949 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20019372 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10335960 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01049974 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0554810 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99679722 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99496693 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 1.93034982 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90865362 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.89548480 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.80561034 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.75882219 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75670653 |
| 30 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.73716391 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70949531 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.69714426 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67207032 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60432498 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56825720 |
| 36 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54292275 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53987902 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53502427 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52613779 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51584028 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50424044 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47935201 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46495770 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46306010 |
| 45 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.44923177 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43155545 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40637999 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37888974 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32831830 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32593171 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32264089 |
| 52 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.30587574 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27202703 |
| 54 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.25997020 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25859794 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25042086 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.24968820 |
| 58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22884828 |
| 59 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21637791 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21555771 |
| 61 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21201597 |
| 62 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.20550513 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19840362 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18247063 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17226807 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17091096 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.16247098 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14638212 |
| 69 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13699379 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13699379 |
| 71 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13616061 |
| 72 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13547220 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12932646 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12893041 |
| 75 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12538315 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11930608 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10340758 |
| 78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10147443 |
| 79 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10119239 |
| 80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09998879 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09749586 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09749586 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09555541 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08599278 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08277536 |
| 86 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07829461 |
| 87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07829461 |
| 88 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07814449 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07195580 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05670365 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05572372 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04270551 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03758187 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03431740 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03337207 |
| 96 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03165849 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03126883 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03068905 |
| 99 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02566971 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02249533 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01299103 |
| 102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.00849052 |
| 103 | GATA3_26560356_Chip-Seq_TH1_Human | 1.00607186 |
| 104 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99590383 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98597673 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98194121 |
| 107 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97884012 |
| 108 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.97831243 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97639075 |
| 110 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96756976 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95726109 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95547254 |
| 113 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95308804 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.94061376 |
| 115 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92872649 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92662367 |
| 117 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.92486456 |
| 118 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92177199 |
| 119 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91926064 |
| 120 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90589553 |
| 121 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90589553 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89491826 |
| 123 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88880823 |
| 124 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88832048 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88798161 |
| 126 | NCOR_22424771_ChIP-Seq_293T_Human | 0.88355567 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.88241821 |
| 128 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.87653159 |
| 129 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87496631 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87280421 |
| 131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.87124963 |
| 132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87009146 |
| 133 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86562229 |
| 134 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86447683 |
| 135 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.85977493 |
| 136 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85954510 |
| 137 | MAF_26560356_Chip-Seq_TH1_Human | 0.85703103 |
| 138 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.85610577 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85587058 |
| 140 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85550931 |
| 141 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84603831 |
| 142 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84396622 |
| 143 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83940719 |
| 144 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81169167 |
| 145 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80623647 |
| 146 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79501135 |
| 147 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79206296 |
| 148 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.78671772 |
| 149 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.78602894 |
| 150 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75484445 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74852961 |
| 152 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74616284 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74592741 |
| 154 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74281190 |
| 155 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72039074 |
| 156 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71499108 |
| 157 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.71475778 |
| 158 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70418935 |
| 159 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70073802 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69669394 |
| 161 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.69645964 |
| 162 | * MYB_26560356_Chip-Seq_TH1_Human | 0.69297485 |
| 163 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68891241 |
| 164 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.68735287 |
| 165 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68508699 |
| 166 | * MAF_26560356_Chip-Seq_TH2_Human | 0.68378416 |
| 167 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.68090506 |
| 168 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.67599007 |
| 169 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67391590 |
| 170 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66713604 |
| 171 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66284783 |
| 172 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66190207 |
| 173 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.65914617 |
| 174 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65913954 |
| 175 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.65832471 |
| 176 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.65104665 |
| 177 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.64383002 |
| 178 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.63221164 |
| 179 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62868547 |
| 180 | UTX_26944678_Chip-Seq_JUKART_Human | 0.62356950 |
| 181 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62269213 |
| 182 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62103745 |
| 183 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61477535 |
| 184 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.60483084 |
| 185 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.59879355 |
| 186 | MYC_22102868_ChIP-Seq_BL_Human | 0.59722285 |
| 187 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.58339971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.06333302 |
| 2 | MP0005360_urolithiasis | 6.66309727 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.75988241 |
| 4 | MP0005365_abnormal_bile_salt | 5.51076979 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.33175780 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.79437467 |
| 7 | MP0003252_abnormal_bile_duct | 3.74002667 |
| 8 | MP0009840_abnormal_foam_cell | 3.42566920 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.25423179 |
| 10 | MP0005083_abnormal_biliary_tract | 3.18385532 |
| 11 | MP0000569_abnormal_digit_pigmentation | 3.07600850 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.67488363 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.56884736 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.56784844 |
| 15 | MP0005332_abnormal_amino_acid | 2.39753711 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.28126457 |
| 17 | MP0000609_abnormal_liver_physiology | 2.25149485 |
| 18 | MP0003195_calcinosis | 2.23699423 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.21633792 |
| 20 | MP0003868_abnormal_feces_composition | 2.08389300 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.03507818 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.03494321 |
| 23 | MP0001501_abnormal_sleep_pattern | 1.94590001 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.93363446 |
| 25 | MP0003787_abnormal_imprinting | 1.87211649 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.87056613 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.86622814 |
| 28 | MP0001819_abnormal_immune_cell | 1.85227290 |
| 29 | MP0005310_abnormal_salivary_gland | 1.84223672 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.80805268 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.76245187 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.72775793 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.72654205 |
| 34 | MP0003646_muscle_fatigue | 1.72423897 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.66313760 |
| 36 | MP0005451_abnormal_body_composition | 1.63082230 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.56205334 |
| 38 | MP0001764_abnormal_homeostasis | 1.52288688 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.49953254 |
| 40 | MP0002405_respiratory_system_inflammati | 1.48944657 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45930604 |
| 42 | MP0000716_abnormal_immune_system | 1.40787962 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.37866369 |
| 44 | MP0005551_abnormal_eye_electrophysiolog | 1.37327774 |
| 45 | MP0002693_abnormal_pancreas_physiology | 1.36012539 |
| 46 | MP0003186_abnormal_redox_activity | 1.35001684 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.34575314 |
| 48 | MP0008872_abnormal_physiological_respon | 1.34393310 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.34366782 |
| 50 | MP0002398_abnormal_bone_marrow | 1.34016442 |
| 51 | MP0009764_decreased_sensitivity_to | 1.33380795 |
| 52 | MP0002163_abnormal_gland_morphology | 1.32767530 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.30772931 |
| 54 | MP0005670_abnormal_white_adipose | 1.30680597 |
| 55 | MP0004142_abnormal_muscle_tone | 1.29883283 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.27110566 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.26694668 |
| 58 | MP0004043_abnormal_pH_regulation | 1.24964162 |
| 59 | MP0002254_reproductive_system_inflammat | 1.23430352 |
| 60 | MP0000598_abnormal_liver_morphology | 1.22735478 |
| 61 | MP0003436_decreased_susceptibility_to | 1.22544370 |
| 62 | MP0008469_abnormal_protein_level | 1.21400961 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.18283714 |
| 64 | MP0002009_preneoplasia | 1.16572216 |
| 65 | MP0009763_increased_sensitivity_to | 1.15238866 |
| 66 | MP0009046_muscle_twitch | 1.14079992 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.13530824 |
| 68 | MP0002933_joint_inflammation | 1.13389195 |
| 69 | MP0003866_abnormal_defecation | 1.11455446 |
| 70 | MP0000685_abnormal_immune_system | 1.10371413 |
| 71 | MP0000427_abnormal_hair_cycle | 1.09907020 |
| 72 | MP0005647_abnormal_sex_gland | 1.09541407 |
| 73 | MP0002722_abnormal_immune_system | 1.09173229 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.06885068 |
| 75 | MP0002971_abnormal_brown_adipose | 1.04776691 |
| 76 | MP0006082_CNS_inflammation | 1.03992688 |
| 77 | MP0003724_increased_susceptibility_to | 1.03016645 |
| 78 | MP0001919_abnormal_reproductive_system | 0.98962420 |
| 79 | MP0002429_abnormal_blood_cell | 0.96527653 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.96377805 |
| 81 | MP0009745_abnormal_behavioral_response | 0.95935513 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.95925675 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.95913079 |
| 84 | MP0001663_abnormal_digestive_system | 0.95645967 |
| 85 | MP0005334_abnormal_fat_pad | 0.95503884 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.94301263 |
| 87 | MP0001968_abnormal_touch/_nociception | 0.92332569 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.91501736 |
| 89 | MP0000371_diluted_coat_color | 0.91224435 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.90182337 |
| 91 | MP0001835_abnormal_antigen_presentation | 0.90118275 |
| 92 | MP0008995_early_reproductive_senescence | 0.89117417 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.88653325 |
| 94 | MP0004742_abnormal_vestibular_system | 0.88475137 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.87213223 |
| 96 | MP0004130_abnormal_muscle_cell | 0.87009005 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.85759925 |
| 98 | MP0000604_amyloidosis | 0.84865240 |
| 99 | MP0005464_abnormal_platelet_physiology | 0.84663453 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.84251755 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.84073823 |
| 102 | MP0005025_abnormal_response_to | 0.83347797 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.81109597 |
| 104 | MP0009785_altered_susceptibility_to | 0.80938704 |
| 105 | MP0001853_heart_inflammation | 0.80623022 |
| 106 | MP0005387_immune_system_phenotype | 0.80465731 |
| 107 | MP0001790_abnormal_immune_system | 0.80465731 |
| 108 | MP0001944_abnormal_pancreas_morphology | 0.80361658 |
| 109 | MP0003011_delayed_dark_adaptation | 0.79072588 |
| 110 | MP0010155_abnormal_intestine_physiology | 0.77822454 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.77619979 |
| 112 | MP0004924_abnormal_behavior | 0.77248975 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.77248975 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.77238474 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.76883156 |
| 116 | MP0005389_reproductive_system_phenotype | 0.76257244 |
| 117 | MP0001800_abnormal_humoral_immune | 0.76242041 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.75682871 |
| 119 | MP0002653_abnormal_ependyma_morphology | 0.75474356 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.75414133 |
| 121 | MP0005535_abnormal_body_temperature | 0.75033107 |
| 122 | MP0003075_altered_response_to | 0.74358465 |
| 123 | MP0003303_peritoneal_inflammation | 0.70916686 |
| 124 | MP0004947_skin_inflammation | 0.70394349 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.70267785 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.69955481 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.68968531 |
| 128 | MP0002796_impaired_skin_barrier | 0.68418850 |
| 129 | MP0002419_abnormal_innate_immunity | 0.66582095 |
| 130 | MP0005266_abnormal_metabolism | 0.66549750 |
| 131 | MP0009115_abnormal_fat_cell | 0.66230759 |
| 132 | MP0010352_gastrointestinal_tract_polyps | 0.63560957 |
| 133 | MP0010368_abnormal_lymphatic_system | 0.62999785 |
| 134 | MP0004185_abnormal_adipocyte_glucose | 0.62772866 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.59961191 |
| 136 | MP0005448_abnormal_energy_balance | 0.58522612 |
| 137 | MP0004510_myositis | 0.58144730 |
| 138 | MP0002723_abnormal_immune_serum | 0.57655622 |
| 139 | MP0005166_decreased_susceptibility_to | 0.56046718 |
| 140 | MP0009697_abnormal_copulation | 0.55977020 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.55837780 |
| 142 | MP0005397_hematopoietic_system_phenotyp | 0.55837780 |
| 143 | MP0003718_maternal_effect | 0.55087470 |
| 144 | MP0008874_decreased_physiological_sensi | 0.54973760 |
| 145 | MP0005084_abnormal_gallbladder_morpholo | 0.53676474 |
| 146 | MP0005220_abnormal_exocrine_pancreas | 0.51643259 |
| 147 | MP0008873_increased_physiological_sensi | 0.51553184 |
| 148 | MP0005395_other_phenotype | 0.51244312 |
| 149 | MP0002970_abnormal_white_adipose | 0.50609610 |
| 150 | MP0001873_stomach_inflammation | 0.49742657 |
| 151 | MP0005000_abnormal_immune_tolerance | 0.49585458 |
| 152 | MP0002928_abnormal_bile_duct | 0.48412486 |
| 153 | MP0003690_abnormal_glial_cell | 0.48381827 |
| 154 | MP0001756_abnormal_urination | 0.48021397 |
| 155 | MP0002452_abnormal_antigen_presenting | 0.47023468 |
| 156 | MP0005671_abnormal_response_to | 0.45795580 |
| 157 | MP0001881_abnormal_mammary_gland | 0.45021343 |
| 158 | MP0006035_abnormal_mitochondrial_morpho | 0.44388132 |
| 159 | MP0004381_abnormal_hair_follicle | 0.44160187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.78671235 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.57475791 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.46436601 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.20303323 |
| 5 | Xanthomatosis (HP:0000991) | 5.89452244 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.79184369 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.46697785 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.34574127 |
| 9 | Complement deficiency (HP:0004431) | 5.10284983 |
| 10 | Joint hemorrhage (HP:0005261) | 4.48244989 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.24151935 |
| 12 | Stomatitis (HP:0010280) | 4.16389644 |
| 13 | Hyperammonemia (HP:0001987) | 4.12568773 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10232744 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.00820905 |
| 16 | Hyperglycinemia (HP:0002154) | 3.97774965 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.94763857 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.88787625 |
| 19 | Ketosis (HP:0001946) | 3.85217711 |
| 20 | Abnormality of complement system (HP:0005339) | 3.84338710 |
| 21 | Hyperglycinuria (HP:0003108) | 3.83755269 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83304914 |
| 23 | Epidermoid cyst (HP:0200040) | 3.80916554 |
| 24 | Fat malabsorption (HP:0002630) | 3.80596317 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.76595892 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63982494 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.63982494 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.61621623 |
| 29 | Myocardial infarction (HP:0001658) | 3.60358245 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56595989 |
| 31 | Pancreatic cysts (HP:0001737) | 3.52773405 |
| 32 | Hypochromic microcytic anemia (HP:0004840) | 3.50630984 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.50053941 |
| 34 | Congenital stationary night blindness (HP:0007642) | 3.49807199 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.48130422 |
| 36 | Stomach cancer (HP:0012126) | 3.46373269 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.39398817 |
| 38 | Genetic anticipation (HP:0003743) | 3.34839049 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34240988 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.32466484 |
| 41 | Hyperventilation (HP:0002883) | 3.25474948 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 3.12161148 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08457987 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.07197447 |
| 45 | IgG deficiency (HP:0004315) | 3.06886680 |
| 46 | Hyperbilirubinemia (HP:0002904) | 3.05811052 |
| 47 | Pancreatic fibrosis (HP:0100732) | 3.04546975 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00306034 |
| 49 | Large for gestational age (HP:0001520) | 2.95001687 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93676271 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 2.92645528 |
| 52 | Abnormality of midbrain morphology (HP:0002418) | 2.92645528 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.90809291 |
| 54 | Steatorrhea (HP:0002570) | 2.84284921 |
| 55 | Ketoacidosis (HP:0001993) | 2.84179566 |
| 56 | Spontaneous abortion (HP:0005268) | 2.83278308 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.82609528 |
| 58 | Progressive cerebellar ataxia (HP:0002073) | 2.79752295 |
| 59 | Acanthocytosis (HP:0001927) | 2.75940730 |
| 60 | Recurrent fungal infections (HP:0002841) | 2.72196319 |
| 61 | Type II lissencephaly (HP:0007260) | 2.71943823 |
| 62 | True hermaphroditism (HP:0010459) | 2.71747442 |
| 63 | Abnormality of B cell number (HP:0010975) | 2.71071110 |
| 64 | Abnormality of purine metabolism (HP:0004352) | 2.70814997 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.67556446 |
| 66 | Attenuation of retinal blood vessels (HP:0007843) | 2.67333282 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.64844713 |
| 68 | Esophageal varix (HP:0002040) | 2.63903403 |
| 69 | Poikilocytosis (HP:0004447) | 2.61725621 |
| 70 | Panhypogammaglobulinemia (HP:0003139) | 2.60866865 |
| 71 | Gingival bleeding (HP:0000225) | 2.57971107 |
| 72 | Nephronophthisis (HP:0000090) | 2.57731862 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56167688 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.56167688 |
| 75 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.55750864 |
| 76 | Malnutrition (HP:0004395) | 2.55495863 |
| 77 | Albinism (HP:0001022) | 2.51993001 |
| 78 | Hepatocellular carcinoma (HP:0001402) | 2.51301075 |
| 79 | Delayed CNS myelination (HP:0002188) | 2.50857902 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.50662822 |
| 81 | Optic neuritis (HP:0100653) | 2.50662822 |
| 82 | Myositis (HP:0100614) | 2.49913282 |
| 83 | Abnormality of T cells (HP:0002843) | 2.49483860 |
| 84 | Fair hair (HP:0002286) | 2.49253481 |
| 85 | Gaze-evoked nystagmus (HP:0000640) | 2.48277377 |
| 86 | Hyperalaninemia (HP:0003348) | 2.46131563 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.46131563 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 2.46131563 |
| 89 | Clumsiness (HP:0002312) | 2.44523236 |
| 90 | Vascular calcification (HP:0004934) | 2.44243476 |
| 91 | Metabolic acidosis (HP:0001942) | 2.43099474 |
| 92 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42113275 |
| 93 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42113275 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.41102968 |
| 95 | Lethargy (HP:0001254) | 2.39718434 |
| 96 | Abnormality of T cell number (HP:0011839) | 2.39208686 |
| 97 | Glomerulonephritis (HP:0000099) | 2.38858456 |
| 98 | Skin nodule (HP:0200036) | 2.37586599 |
| 99 | Amyloidosis (HP:0011034) | 2.37563119 |
| 100 | Abnormality of the renal medulla (HP:0100957) | 2.37193252 |
| 101 | Abnormality of the prostate (HP:0008775) | 2.35564943 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 2.35109123 |
| 103 | Cholelithiasis (HP:0001081) | 2.34180479 |
| 104 | Gout (HP:0001997) | 2.34004033 |
| 105 | Abnormal gallbladder morphology (HP:0012437) | 2.30992984 |
| 106 | Prostate neoplasm (HP:0100787) | 2.29217464 |
| 107 | Polycythemia (HP:0001901) | 2.28730846 |
| 108 | Febrile seizures (HP:0002373) | 2.28438089 |
| 109 | Polydipsia (HP:0001959) | 2.24733942 |
| 110 | Abnormal drinking behavior (HP:0030082) | 2.24733942 |
| 111 | Reticulocytosis (HP:0001923) | 2.23760202 |
| 112 | Medial flaring of the eyebrow (HP:0010747) | 2.23267414 |
| 113 | B lymphocytopenia (HP:0010976) | 2.22342026 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 2.21702396 |
| 115 | Irritability (HP:0000737) | 2.21606352 |
| 116 | Alveolar cell carcinoma (HP:0006519) | 2.21537577 |
| 117 | Recurrent bronchitis (HP:0002837) | 2.21105364 |
| 118 | Autoimmune thrombocytopenia (HP:0001973) | 2.20982402 |
| 119 | Protruding tongue (HP:0010808) | 2.20146304 |
| 120 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.19993002 |
| 121 | Menorrhagia (HP:0000132) | 2.19498953 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 2.19270460 |
| 123 | Pancreatitis (HP:0001733) | 2.19121634 |
| 124 | Abnormality of eosinophils (HP:0001879) | 2.18622465 |
| 125 | Spastic diplegia (HP:0001264) | 2.17567507 |
| 126 | Orchitis (HP:0100796) | 2.16446808 |
| 127 | T lymphocytopenia (HP:0005403) | 2.16439215 |
| 128 | Pulmonary infiltrates (HP:0002113) | 2.15641598 |
| 129 | Chronic hepatic failure (HP:0100626) | 2.14449864 |
| 130 | Hypochromic anemia (HP:0001931) | 2.14362034 |
| 131 | Thrombophlebitis (HP:0004418) | 2.13930380 |
| 132 | Vasculitis (HP:0002633) | 2.13518553 |
| 133 | Generalized hypopigmentation of hair (HP:0011358) | 2.13084390 |
| 134 | Cholecystitis (HP:0001082) | 2.12774471 |
| 135 | Abnormal gallbladder physiology (HP:0012438) | 2.12774471 |
| 136 | Eosinophilia (HP:0001880) | 2.10670715 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10338647 |
| 138 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10199035 |
| 139 | Absent/shortened dynein arms (HP:0200106) | 2.07799573 |
| 140 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.07799573 |
| 141 | Cardiovascular calcification (HP:0011915) | 2.06726411 |
| 142 | Widely spaced teeth (HP:0000687) | 2.06007640 |
| 143 | Thyroiditis (HP:0100646) | 2.03150156 |
| 144 | Furrowed tongue (HP:0000221) | 2.02761593 |
| 145 | Neonatal onset (HP:0003623) | 2.01959742 |
| 146 | Mitral stenosis (HP:0001718) | 2.01719301 |
| 147 | Encephalitis (HP:0002383) | 2.01310047 |
| 148 | Increased serum ferritin (HP:0003281) | 1.99565721 |
| 149 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.99491280 |
| 150 | Renal cortical cysts (HP:0000803) | 1.97972113 |
| 151 | Tubular atrophy (HP:0000092) | 1.97225490 |
| 152 | Late onset (HP:0003584) | 1.96384641 |
| 153 | Hypoglycemic seizures (HP:0002173) | 1.95911308 |
| 154 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95809514 |
| 155 | Hemoptysis (HP:0002105) | 1.94823021 |
| 156 | Generalized aminoaciduria (HP:0002909) | 1.93847214 |
| 157 | Sensorimotor neuropathy (HP:0007141) | 1.93106686 |
| 158 | Inability to walk (HP:0002540) | 1.92166356 |
| 159 | Mediastinal lymphadenopathy (HP:0100721) | 1.91404315 |
| 160 | Vomiting (HP:0002013) | 1.90897368 |
| 161 | Hypertriglyceridemia (HP:0002155) | 1.89716749 |
| 162 | Brushfield spots (HP:0001088) | 1.88328787 |
| 163 | Pustule (HP:0200039) | 1.88097918 |
| 164 | Rickets (HP:0002748) | 1.87780153 |
| 165 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87563707 |
| 166 | Nephritis (HP:0000123) | 1.87386795 |
| 167 | Hematochezia (HP:0002573) | 1.87329704 |
| 168 | Abnormality of the pons (HP:0007361) | 1.87313157 |
| 169 | Eczematoid dermatitis (HP:0000976) | 1.85964774 |
| 170 | Abnormality of the gallbladder (HP:0005264) | 1.85652454 |
| 171 | Nausea (HP:0002018) | 1.84550741 |
| 172 | Recurrent bacterial skin infections (HP:0005406) | 1.84492168 |
| 173 | Cystic liver disease (HP:0006706) | 1.84217799 |
| 174 | Leukocytosis (HP:0001974) | 1.83241071 |
| 175 | Hydroxyprolinuria (HP:0003080) | 1.83146610 |
| 176 | Abnormality of proline metabolism (HP:0010907) | 1.83146610 |
| 177 | Status epilepticus (HP:0002133) | 1.82691019 |
| 178 | Decreased circulating renin level (HP:0003351) | 1.80186980 |
| 179 | Cerebral edema (HP:0002181) | 1.80173642 |
| 180 | Epistaxis (HP:0000421) | 1.79822120 |
| 181 | Microcytic anemia (HP:0001935) | 1.79364599 |
| 182 | Abnormal cartilage morphology (HP:0002763) | 1.78581582 |
| 183 | Chronic diarrhea (HP:0002028) | 1.75501605 |
| 184 | Chronic otitis media (HP:0000389) | 1.75243522 |
| 185 | Severe visual impairment (HP:0001141) | 1.75156129 |
| 186 | Granulocytopenia (HP:0001913) | 1.74344259 |
| 187 | Keratoconjunctivitis (HP:0001096) | 1.74097150 |
| 188 | Recurrent skin infections (HP:0001581) | 1.72679202 |
| 189 | Hypoplastic iliac wings (HP:0002866) | 1.72509994 |
| 190 | Meningitis (HP:0001287) | 1.71957600 |
| 191 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71092320 |
| 192 | Decreased central vision (HP:0007663) | 1.69781209 |
| 193 | Parakeratosis (HP:0001036) | 1.69115484 |
| 194 | Polyuria (HP:0000103) | 1.66461470 |
| 195 | Progressive inability to walk (HP:0002505) | 1.65214178 |
| 196 | Absence seizures (HP:0002121) | 1.64960672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.79437413 |
| 2 | ERN1 | 4.74796605 |
| 3 | FGFR4 | 3.78017685 |
| 4 | TXK | 3.65182242 |
| 5 | BCKDK | 3.56523662 |
| 6 | TAOK3 | 3.53783861 |
| 7 | SIK1 | 3.03801020 |
| 8 | ADRBK2 | 2.74914721 |
| 9 | TYK2 | 2.51914138 |
| 10 | TRIB3 | 2.49769840 |
| 11 | ACVR1B | 2.30323187 |
| 12 | CAMKK2 | 2.12240888 |
| 13 | TBK1 | 2.08788282 |
| 14 | MAP4K1 | 2.02097612 |
| 15 | MAP3K14 | 1.93346191 |
| 16 | IRAK3 | 1.87002464 |
| 17 | BMPR1B | 1.82640859 |
| 18 | MAP3K10 | 1.79276208 |
| 19 | TEC | 1.77269747 |
| 20 | ITK | 1.76767183 |
| 21 | GRK6 | 1.76716603 |
| 22 | GRK1 | 1.72526207 |
| 23 | CDK12 | 1.71272258 |
| 24 | EPHB1 | 1.69525486 |
| 25 | TNK2 | 1.66579629 |
| 26 | MAPK11 | 1.59706360 |
| 27 | MAPK15 | 1.50656635 |
| 28 | ERBB4 | 1.50598165 |
| 29 | MAP3K11 | 1.48464206 |
| 30 | NUAK1 | 1.48442945 |
| 31 | JAK1 | 1.48127496 |
| 32 | PKN2 | 1.45165205 |
| 33 | IKBKE | 1.40643533 |
| 34 | MAP3K13 | 1.40601338 |
| 35 | CSK | 1.39598046 |
| 36 | MST1R | 1.37693642 |
| 37 | LATS1 | 1.37247302 |
| 38 | MAP2K3 | 1.36563955 |
| 39 | TLK1 | 1.34362105 |
| 40 | JAK2 | 1.32708369 |
| 41 | JAK3 | 1.32337973 |
| 42 | ZAK | 1.30752319 |
| 43 | MARK3 | 1.30546521 |
| 44 | CSF1R | 1.28036888 |
| 45 | MAP3K6 | 1.25094559 |
| 46 | WNK4 | 1.23761824 |
| 47 | SIK3 | 1.23582827 |
| 48 | NLK | 1.21251984 |
| 49 | PTK6 | 1.18608166 |
| 50 | ICK | 1.18205726 |
| 51 | OXSR1 | 1.16834642 |
| 52 | IRAK1 | 1.16077686 |
| 53 | PRKAA2 | 1.15963381 |
| 54 | ABL2 | 1.15823767 |
| 55 | BLK | 1.13186072 |
| 56 | IRAK4 | 1.12168677 |
| 57 | STK3 | 1.08499245 |
| 58 | TAOK1 | 1.05853413 |
| 59 | LCK | 1.03796350 |
| 60 | EPHA3 | 1.03002235 |
| 61 | FES | 1.02360397 |
| 62 | MAP3K3 | 1.02321363 |
| 63 | RIPK1 | 1.00297188 |
| 64 | PASK | 0.97903479 |
| 65 | IKBKB | 0.97079751 |
| 66 | STK16 | 0.95806430 |
| 67 | ADRBK1 | 0.91768536 |
| 68 | INSRR | 0.88778057 |
| 69 | MAP4K2 | 0.88583671 |
| 70 | SGK2 | 0.88320217 |
| 71 | NME2 | 0.88188886 |
| 72 | MAPK13 | 0.87835925 |
| 73 | LYN | 0.87063102 |
| 74 | DAPK2 | 0.86768046 |
| 75 | CDK6 | 0.86706163 |
| 76 | NEK9 | 0.85979902 |
| 77 | MST4 | 0.84036238 |
| 78 | DYRK1B | 0.82535690 |
| 79 | CAMK1D | 0.81090159 |
| 80 | MAP3K1 | 0.81012477 |
| 81 | MAP2K6 | 0.80731703 |
| 82 | CDK4 | 0.79936458 |
| 83 | PTK2B | 0.79078675 |
| 84 | PIK3CA | 0.78366938 |
| 85 | AKT3 | 0.77936273 |
| 86 | PAK3 | 0.77810313 |
| 87 | PIM1 | 0.77426627 |
| 88 | MAP3K7 | 0.76534930 |
| 89 | MAP2K4 | 0.75282283 |
| 90 | CAMKK1 | 0.74418716 |
| 91 | PINK1 | 0.73976537 |
| 92 | WNK3 | 0.73455176 |
| 93 | CHUK | 0.70755809 |
| 94 | PRKAA1 | 0.70096747 |
| 95 | BMX | 0.68783629 |
| 96 | MAPK4 | 0.68498232 |
| 97 | ZAP70 | 0.68342130 |
| 98 | CDK19 | 0.64841931 |
| 99 | FGFR3 | 0.64532341 |
| 100 | GRK7 | 0.64061558 |
| 101 | MAP2K2 | 0.63345506 |
| 102 | KIT | 0.63313167 |
| 103 | SIK2 | 0.62912169 |
| 104 | MTOR | 0.62673219 |
| 105 | STK10 | 0.60448084 |
| 106 | MAPK7 | 0.60276215 |
| 107 | TRPM7 | 0.60051474 |
| 108 | OBSCN | 0.59966757 |
| 109 | BMPR2 | 0.59479655 |
| 110 | MKNK2 | 0.59223194 |
| 111 | PRKD2 | 0.59127538 |
| 112 | GSK3A | 0.59118750 |
| 113 | HCK | 0.58887607 |
| 114 | PDPK1 | 0.57923857 |
| 115 | FLT3 | 0.57142585 |
| 116 | MAPKAPK3 | 0.55774270 |
| 117 | MATK | 0.55302706 |
| 118 | STK11 | 0.55231775 |
| 119 | IRAK2 | 0.53504849 |
| 120 | MAP3K5 | 0.51121419 |
| 121 | TIE1 | 0.51104952 |
| 122 | EPHA2 | 0.50752168 |
| 123 | KDR | 0.50631895 |
| 124 | TGFBR1 | 0.49977765 |
| 125 | SGK3 | 0.49845796 |
| 126 | PDK1 | 0.48196452 |
| 127 | PIM2 | 0.47538622 |
| 128 | CAMK4 | 0.47290611 |
| 129 | TNIK | 0.47012987 |
| 130 | STK4 | 0.46865574 |
| 131 | RPS6KA6 | 0.46568695 |
| 132 | MOS | 0.45193717 |
| 133 | RIPK4 | 0.44930173 |
| 134 | MAPK12 | 0.44843360 |
| 135 | HIPK2 | 0.44712072 |
| 136 | EGFR | 0.44476221 |
| 137 | TGFBR2 | 0.43030945 |
| 138 | PRKCH | 0.42939676 |
| 139 | BTK | 0.42238831 |
| 140 | PIK3CG | 0.41957626 |
| 141 | ERBB2 | 0.41794551 |
| 142 | PRKCQ | 0.41678085 |
| 143 | EEF2K | 0.41552555 |
| 144 | SYK | 0.39802052 |
| 145 | PRKCZ | 0.39755998 |
| 146 | PRKCE | 0.39344567 |
| 147 | MAP3K8 | 0.38673252 |
| 148 | CAMK1G | 0.38224672 |
| 149 | PRKCI | 0.37933771 |
| 150 | ABL1 | 0.37852696 |
| 151 | RPS6KB2 | 0.37242287 |
| 152 | SGK494 | 0.36623052 |
| 153 | SGK223 | 0.36623052 |
| 154 | RPS6KA5 | 0.34756714 |
| 155 | WNK1 | 0.34550706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.48632520 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32743918 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31941149 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27345408 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.14925978 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78622791 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64507875 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52189726 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49122864 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43914373 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43481147 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.27182602 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.24444723 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24368838 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.20530172 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.18466633 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.13683717 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.11397924 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10652467 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06670836 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.04533204 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.00160020 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96614783 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93983444 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93235060 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.93004221 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.87267764 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82236810 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82163649 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80863668 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79084203 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.78301046 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76030514 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75268261 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75024888 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73320526 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72636501 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.70752383 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68823295 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64128521 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.54622314 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53255868 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.50369978 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.49840525 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46285473 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46079890 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45819666 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45476887 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41814776 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 1.41143852 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40668062 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40642883 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36424067 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30531644 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30410797 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29106061 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29097295 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29066325 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27233366 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27023764 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26811806 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24494636 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23867616 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22430558 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20822455 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.19439319 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18737039 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17700337 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15491373 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10566078 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08746838 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07176225 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06715229 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00331352 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98199124 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95772463 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.95534579 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.92838935 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91933895 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90432840 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88836995 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88250394 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86253795 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85678785 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.84778916 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84756430 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81126347 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80967209 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.80245313 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80092219 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77503755 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77350487 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76110300 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.72887494 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72474846 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72251933 |
| 97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70333788 |
| 98 | RNA polymerase_Homo sapiens_hsa03020 | 0.70249886 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69873648 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66822460 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65526290 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63775214 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63266057 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62744955 |
| 105 | Homologous recombination_Homo sapiens_hsa03440 | 0.61171546 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59162904 |
| 107 | Protein export_Homo sapiens_hsa03060 | 0.57688948 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55504808 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54107214 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.53056628 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50900332 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | 0.50627142 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50589131 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50468015 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49820110 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.48774427 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48697143 |
| 118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48444433 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48118830 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.47887517 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.47333450 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46174441 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46155561 |
| 124 | Taste transduction_Homo sapiens_hsa04742 | 0.44269056 |
| 125 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42181683 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39946375 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39268684 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38232867 |
| 129 | Nicotine addiction_Homo sapiens_hsa05033 | 0.37511994 |
| 130 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37027891 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36378017 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36358742 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35456923 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.35343381 |
| 135 | Lysosome_Homo sapiens_hsa04142 | 0.34523404 |
| 136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26083332 |
| 137 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.18487140 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15774084 |
| 139 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.15216114 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12038910 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11685663 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10577650 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.08879956 |
| 144 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.06988142 |
| 145 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.06486602 |
| 146 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.01246158 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01190727 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.00920689 |
| 149 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.00639114 |
| 150 | Primary immunodeficiency_Homo sapiens_hsa05340 | -0.0563410 |
| 151 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.0468929 |
| 152 | Measles_Homo sapiens_hsa05162 | -0.0367339 |
| 153 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | -0.0348795 |
| 154 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0330486 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0234026 |
| 156 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0233350 |
| 157 | Influenza A_Homo sapiens_hsa05164 | -0.0217568 |
| 158 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0152344 |
| 159 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0122266 |
| 160 | Legionellosis_Homo sapiens_hsa05134 | -0.0098986 |

